PDCD1 and myocarditis: Until now there are no specific clinical manifestations or laboratory biomarkers for PD-1/PD-L1 inhibitors associated myocarditis (Puzanov et al., 2017; Brahmer et al., 2018; Curigliano et al., 2020; Thompson et al., 2021).